Coloma Jason V (CIK 1676170) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell MAZE (2,593 shares), Sell MAZE (30,311 shares), Sell MAZE (1,597 shares), Sell MAZE (1,953 shares), Sell MAZE (2,040 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,593 | $77,726 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 30,311 | $907,921 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,597 | $48,606 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,953 | $50,781 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,040 | $53,040 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 23,865 | $621,674 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 6,090 | $159,537 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 553 | $14,511 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,822 | $47,372 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 116 | $3,016 |
Source: SEC Form 4 filings · as of 2026-07-02